OA08478A - Vaccin contre la mélanome. - Google Patents

Vaccin contre la mélanome.

Info

Publication number
OA08478A
OA08478A OA59065A OA59065A OA08478A OA 08478 A OA08478 A OA 08478A OA 59065 A OA59065 A OA 59065A OA 59065 A OA59065 A OA 59065A OA 08478 A OA08478 A OA 08478A
Authority
OA
OAPI
Prior art keywords
melanoma vaccine
melanoma
vaccine
Prior art date
Application number
OA59065A
Other languages
English (en)
Inventor
Joseph P Brown
Gregory D Plowwman
Karl E Hellstrom
Anthony F Purchio
Stridhar Pennathur
D Charles
Timothy M Rose
Ingegerd Hellstrom
Shiu-Lok Hu
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26676698&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=OA08478(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/007,230 external-priority patent/US5262177A/en
Application filed by Oncogen filed Critical Oncogen
Publication of OA08478A publication Critical patent/OA08478A/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00119—Melanoma antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
OA59065A 1986-02-07 1987-02-06 Vaccin contre la mélanome. OA08478A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82731386A 1986-02-07 1986-02-07
US07/007,230 US5262177A (en) 1986-02-07 1987-01-27 Recombinant viruses encoding the human melanoma-associated antigen

Publications (1)

Publication Number Publication Date
OA08478A true OA08478A (fr) 1988-07-29

Family

ID=26676698

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59065A OA08478A (fr) 1986-02-07 1987-02-06 Vaccin contre la mélanome.

Country Status (18)

Country Link
JP (3) JP2664673B2 (fr)
BE (1) BE1000175A3 (fr)
CH (1) CH675424A5 (fr)
DE (1) DE3703702C2 (fr)
DK (1) DK63287A (fr)
ES (2) ES2012815A6 (fr)
FI (1) FI94836C (fr)
GR (1) GR870195B (fr)
HU (1) HU209144B (fr)
IE (1) IE59597B1 (fr)
IT (1) IT1222359B (fr)
MX (1) MX9203574A (fr)
NL (1) NL8700285A (fr)
NO (1) NO178931C (fr)
NZ (1) NZ219192A (fr)
OA (1) OA08478A (fr)
PT (1) PT84255B (fr)
SE (2) SE506024C2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19821925A1 (de) * 1998-05-15 1999-11-18 Roehnisch Tim Verfahren zur Herstellung einer Zusammensetzung zur Induktion einer tumorspezifischen Immunantwort, sowie Verwendung der Zusammensetzung zur Behandlung von Neoplasien
JP4414023B2 (ja) * 1999-08-05 2010-02-10 オリエンタル酵母工業株式会社 関節炎関連メラノトランスフェリンの測定方法および試薬
JP4708027B2 (ja) * 2002-10-01 2011-06-22 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 抗癌組成物および抗感染疾患組成物ならびにこれらを使用する方法
US8207314B2 (en) * 2003-05-16 2012-06-26 Sanofi Pasteur Limited Tumor antigens for prevention and/or treatment of cancer

Also Published As

Publication number Publication date
FI870501A (fi) 1987-08-08
IE59597B1 (en) 1994-03-09
SE8700466D0 (sv) 1987-02-06
HUT43107A (en) 1987-09-28
HU209144B (en) 1994-03-28
DK63287A (da) 1987-08-08
FI94836B (fi) 1995-07-31
IE870319L (en) 1987-08-07
JP2664673B2 (ja) 1997-10-15
IT8719291A0 (it) 1987-02-06
NZ219192A (en) 1991-10-25
DK63287D0 (da) 1987-02-06
GR870195B (en) 1987-06-10
FI94836C (fi) 1995-11-10
NO178931C (no) 1996-07-03
JPH09135692A (ja) 1997-05-27
NL8700285A (nl) 1987-09-01
PT84255B (pt) 1989-11-30
SE506024C2 (sv) 1997-11-03
BE1000175A3 (fr) 1988-07-12
DE3703702C2 (de) 1997-07-10
JPH08280390A (ja) 1996-10-29
CH675424A5 (en) 1990-09-28
PT84255A (en) 1987-03-01
IT1222359B (it) 1990-09-05
NO178931B (no) 1996-03-25
NO870475L (no) 1987-08-10
FI870501A0 (fi) 1987-02-06
NO870475D0 (no) 1987-02-06
ES2017258A6 (es) 1991-01-16
ES2012815A6 (es) 1990-04-16
JPS62294698A (ja) 1987-12-22
DE3703702A1 (de) 1988-02-18
SE8700466L (sv) 1987-08-08
SE9202934D0 (sv) 1992-10-07
MX9203574A (es) 1992-07-01

Similar Documents

Publication Publication Date Title
FR2601370B1 (fr) Vaccin contre le melanome.
DE3785404D1 (de) Impfstoffe.
NO875191L (no) Silisiumkarbid - slipemiddel.
ES2015061B3 (es) Ingrediente antiespuma.
FI882397A (fi) Vaccin och framstaellningsfoerfarande.
NO873080D0 (no) Mikrobicid tilberedning.
DE3763226D1 (de) Verankerung.
NL990018I1 (nl) Vaccin tegen Pasteurella.
DE3787051D1 (de) Immunotestverfahren.
KR890700356A (ko) 신규의 백신
FI875039A0 (fi) Terapeutiska sammansaettningar foer veterinaermedicinsk anvaendning.
DE3786301T2 (de) Kombinierter Impfstoff.
NO875038D0 (no) Konjugert vaksine.
OA08478A (fr) Vaccin contre la mélanome.
DE3782960D1 (de) Impfstoffe.
FI872802A (fi) Vaccin mot protozonparasiter.
DK375488D0 (da) Vaccine
FI874509A0 (fi) Fallfoerhindrande saekerhetsanordning.
NO864764L (no) Vaksine.
ATE83154T1 (de) Impfstoffe.
DE3779276D1 (de) Analgetisches praeparat.
MX9203545A (es) Formulaciones farmaceuticas.
DK653388A (da) Vaccine
BR6601453U (pt) Poltrona
IT1216292B (it) Manichino per vetrina.